Skip to main content
. 2020 Oct 22;61(11):965–969. doi: 10.3349/ymj.2020.61.11.965

Table 1. Patient Characteristics.

Total (n=390) Composite outcomes p
No event (n=345) Event (n=45)
Age (yr) 66.7±11.9 66.4±11.7 69.4±13.0 0.110
Male sex 219 (56.2) 195 (56.5) 24 (53.3) 0.806
Hypertension 273 (70.0) 237 (68.7) 36 (80.0) 0.167
Diabetes 107 (27.4) 99 (28.7) 8 (17.8) 0.172
Dyslipidemia 160 (41.0) 143 (41.4) 17 (37.8) 0.757
Chronic kidney disease 17 (4.4) 13 (3.8) 4 (8.9) 0.232
Vascular disease 12 (3.1) 10 (2.9) 2 (4.4) 0.916
Coronary artery disease 41 (10.5) 37 (10.7) 4 (8.9) 0.905
Cigarette smokers 148 (37.9) 127 (36.8) 21 (46.7) 0.264
Echocardiographic parameters
 LA diameter (mm) 36.4±4.5 36.2±4.4 37.7±5.0 0.044
 LA volume (mm3) 41.2±11.8 40.5±11.5 46.1±12.9 0.003
 LA volume index (mm3/m2) 24.5±6.9 24.1±6.5 28.0±8.6 0.005
 LVEF (%) 66.6±8.8 66.7±8.7 66.0±9.1 0.612
 LV mass index (g/m2) 106.1±28.9 105.3±27.1 112.4±40.2 0.279
 E/e′ 12.0±4.5 11.8±4.1 13.5±6.2 0.082
 PACs (n) 541.0±2565.7 537.4±2608.8 568.5±2233.7 0.939
 Frequent PACs 210 (53.8) 178 (51.6) 32 (71.1) 0.017
Medication
 Aspirin 301 (77.2) 264 (76.5) 37 (82.2) 0.504
 Triflusal 203 (52.1) 182 (52.8) 21 (46.7) 0.542
 Clopidogrel 30 (7.7) 29 (8.4) 1 (2.2) 0.243

LA, left atrial; LV, left ventricular; LVEF, left ventricular ejection fraction; PAC, premature atrial contractions.

Data are presented as n (%).